AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Challenges and Developments in Digital Health Companies and Direct-to-Consumer Marketing
The chapter delves into the obstacles faced by digital health companies going public through SPACs, the introduction of Pfizer's direct-to-consumer marketing platform, and new FTC regulations for medication advertising. It also discusses the launch of Lilly, declining fertility rates, and the impact of direct-to-consumer marketing on patients' perception of drug prices.